Clinical Trial Update: Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating a vaccine therapy with or without Polysaccharide-K in patients with stage IV HER2-positive breast cancer receiving HER2-targeted th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Polysaccharide-K (polysaccharide-K)
• Vaccine Therapy (unnamed in snippet)

Snippet

Sponsor: University of Washington | Conditions: HER2/Neu Positive, Recurrent Breast Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-04-18